Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Repeated vaccination of inactivated SARS-CoV-2 vaccine dampens neutralizing antibodies against Omicron variants in breakthrough infection
Bo Gao, Liheng He, Yu-Jie Bao, et al.
Cell Research (2023) Vol. 33, Iss. 3, pp. 258-261
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Impact of National Omicron Outbreak at the end of 2022 on the future outlook of COVID-19 in China
Liwei Zheng, Shuying Liu, Fengmin Lu
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 46
Low levels of neutralizing antibodies against XBB Omicron subvariants after BA.5 infection
H. J. Yang, Weiqi Hong, Lei Hong, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 39
A recombinant protein vaccine induces protective immunity against SARS-CoV-2 JN.1 and XBB-lineage subvariants
H. J. Yang, Weiqi Hong, Shi H, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Long COVID: the next public health crisis is already on its way
Chengliang Yang, Scott J. Tebbutt
The Lancet Regional Health - Europe (2023) Vol. 28, pp. 100612-100612
Open Access | Times Cited: 22
Neutralization against Omicron subvariants after BA.5/BF.7 breakthrough infection weakened as virus evolution and aging despite repeated prototype-based vaccination 1
Hongyu Wang, Quanlin Xue, Haocheng Zhang, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 21
Relative effectiveness of a heterologous booster dose with adenovirus type 5 vectored COVID-19 vaccine versus three doses of inactivated COVID-19 vaccine in adults during a nationwide outbreak of omicron predominance, in China: a retrospective, individually matched cohort-control study
Siyue Jia, Zundong Yin, Hongxing Pan, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 5
The appearance of anti-spike receptor binding domain immunoglobulin G4 responses after repetitive immunization with messenger RNA-based COVID-19 vaccines
Michinobu Yoshimura, Atsuhiko Sakamoto, Ryo Ozuru, et al.
International Journal of Infectious Diseases (2023) Vol. 139, pp. 1-5
Open Access | Times Cited: 13
Incidence and severity of SARS‐CoV‐2 reinfection, a multicenter cohort study in Shanghai, China
Weien Yu, Yue Guo, Tiantian Hu, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 8
Closed Access | Times Cited: 11
Neutralizing antibody test supports booster strategy for young individuals after SARS-CoV-2 Omicron breakthrough
Yichuan Yao, Yunru Yang, Qiqin Wu, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access
Dynamic Changes and Trends of SARS‐CoV‐2 Antibodies Induced by Infection and Vaccination Across Multiple Time Points
S.P. Zhang, Xiaoxiao Kong, Qian Zhen, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 1
Open Access
Antibody responses in Omicron BF.7-infected patients vaccinated with inactivated SARS-CoV-2
Yabo Zhao, Weili Li, Liming Xu, et al.
Virology (2025) Vol. 603, pp. 110404-110404
Closed Access
Neutralizing antibody responses to three XBB protein vaccines in older adults
Guo‐Jian Yang, Mei Lu, Rui-Rui Chen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Natural Infection of Omicron BA.5.2 in Patients Provides Broad Immune Responses Against SARS-CoV-2
Le Li, Feng Tang, Quan Shen, et al.
Microorganisms (2025) Vol. 13, Iss. 4, pp. 746-746
Open Access
A distinctive IGHV3-66 SARS-CoV-2 neutralizing antibody elicited by primary infection with an Omicron variant
Qing Fan, Congcong Liu, Huimin Guo, et al.
Structure (2025)
Closed Access
Multiple infections with Omicron variants increase breadth and potency of Omicron-specific neutralizing antibodies
Lei You, Luning Zhang, Shengqun Ouyang, et al.
Cell Discovery (2025) Vol. 11, Iss. 1
Open Access
Neutralization of SARS-CoV-2 BQ.1.1 and XBB.1.5 by Breakthrough Infection Sera from Previous and Current Waves in China
Xun Wang, Shuai Jiang, Shujun Jiang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 9
Longitudinal Analysis of Humoral and Cellular Immune Response up to 6 Months after SARS-CoV-2 BA.5/BF.7/XBB Breakthrough Infection and BA.5/BF.7-XBB Reinfection
Xun Wang, M Zhang, Kaifeng Wei, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 464-464
Open Access | Times Cited: 3
Repeated Omicron infection dampens immune imprinting from previous vaccination and induces broad neutralizing antibodies against Omicron sub-variants
Xiaohua Gong, Ling Peng, Fuxiang Wang, et al.
Journal of Infection (2024) Vol. 89, Iss. 2, pp. 106208-106208
Open Access | Times Cited: 3
Efficacy, immunogenicity, and safety of a monovalent mRNA vaccine, ABO1020, in adults: A randomized, double-blind, placebo-controlled, phase 3 trial
Suad Hannawi, Xiaohong Wu, Ralph Elvi Villalobos, et al.
Med (2024) Vol. 5, Iss. 10, pp. 1282-1292.e3
Open Access | Times Cited: 3
Development of a Recombinant Adeno-Associated Virus Vaccine Expressing PEDV S1 Protein: Enhanced Humoral and Cellular Immunity with Superior Neonatal Protection
Maonan Pang, Meishen Ren, Dike Jiang, et al.
Research Square (Research Square) (2025)
Closed Access
Heterologous boost with mRNA vaccines against SARS-CoV-2 Delta/Omicron variants following an inactivated whole-virus vaccine
Changrui Lu, Yuntao Zhang, Xiaohu Liu, et al.
Antiviral Research (2023) Vol. 212, pp. 105556-105556
Open Access | Times Cited: 7
Inactivated COVID-19 vaccines: potential concerns of antibody-dependent enhancement and original antigenic sin
Andy Ka Chun Kan, Philip H. Li
Immunology Letters (2023) Vol. 259, pp. 21-23
Open Access | Times Cited: 6
Effect of inactivated vaccine boosters against severe and critical COVID‐19 during the Omicron BA.5 wave: A retrospective analysis of hospitalized patients in China
Jiadi Gan, Huohuo Zhang, Jiaxuan Wu, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 2
Closed Access | Times Cited: 2
Current German Recommendations and International Research on the Use of COVID-19 Boosters among Health Care Providers in 2024: A Narrative Review
Poramate Pitak‐Arnnop, Popchai Ngamskulrungroj, Nithi Mahanonda, et al.
Medicina (2024) Vol. 60, Iss. 3, pp. 385-385
Open Access | Times Cited: 2
Efficacy, safety, and immunogenicity of SARS-CoV-2 mRNA vaccine (Omicron BA.5) LVRNA012: a randomized, double-blind, placebo-controlled phase 3 trial
Huan Zhou, Huijuan Zheng, Yucai Peng, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top